CLINICAL_TRIALS
trial_result
· 2009-09-15
Clinical Trial Update: Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation [Phase 3]
Summary
Phase 3 trial evaluating the pharmacodynamics of Tafluprost 0.0015% eye drops, comparing preserved and unpreserved formulations.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santen Oy | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-09-15